GATE-101 | Interleukin Related interleukin-related.com

Product Name :
GATE-101

Search keywords :
Metabotropic Glutamate Receptor 3

drugId :
null

Target Vo:
Metabotropic glutamate receptor 2

Target Vo Short Name :
GRM2

Moa_Name:
Metabotropic glutamate receptor 2 antagonists

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Gate Neurosciences Inc

Active Company_Name :

Active Indication_Name:
Depressive Disorder, Major

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Phase 1 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Cytochrome P450 17A1 Antibody
beta III Tubulin Antibody
NMDAR2A Antibody: NMDAR2A Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 165 kDa, targeting to NMDAR2A. It can be used for WB,IHC-P,IF assays with tag free, in the background of Human, Mouse, Rat.

Author: Interleukin Related

Related Posts